HOME >> BIOLOGY >> NEWS
First Evidence That Localized Arthritis Gene Therapy Heals Distant Diseased Joints

Local production of the modified TNF" and IL-1 receptors would be expected to "mop up" extra TNF" and IL-1 before they could bind to receptors on synoviocytes.

The researchers induced arthritis in both knees of 32 rabbits. One day later, some rabbits received the gene for the receptor to TNF" in one diseased knee. (The second knee served as a control). Other rabbits received the gene for the receptor to IL-1 in one diseased knee. A third group of rabbits received genes for both IL-1 receptor and TNF" receptor in one diseased knee. A fourth group of rabbits received a control injection of saline solution or an irrelevant gene in one diseased knee.

The IL-1 receptor gene or the IL-1 receptor gene given together with the TNF" receptor gene lessened inflammation and cartilage destruction in the rabbit joints. To detect these effects, the researchers collected joint fluid and found reductions in the number of white blood cells (indicative of inflammation) and the amount of proteins normally associated with cartilage destruction. Unexpectedly, the investigators found that the altered IL-1 receptor gene, alone or together with altered TNF" receptor gene diminished arthritic effects in untreated, distant knee joints.

"The best therapeutic effect appears when the IL-1 receptor gene and the TNF" receptor gene are combined," noted Dr. Ghivizzani. "Knees injected with both these genes showed an 85-90 percent reduction in white blood cell levels compared with untreated knees, and a similar protection of cartilage."

In a related experiment, the investigators injected an adenovirus containing a marker gene into one knee of several rabbits. Although not therapeutic, a marker gene allows scientists to easily track the distribution of introduced genes within the body. Seven days after injecting the marker gene, the researchers analyzed tissues and fluids from both rabbit knee joints. They found the marker gene had been
'"/>

Contact: Lauren Ward
wardla@a1.isd.upmc.edu
412-624-2607
University of Pittsburgh Medical Center
14-Apr-1998


Page: 1 2 3 4

Related biology news :

1. First glimpse of DNA binding to viral enzyme
2. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
3. 2nd media alert First Scientific Conference on Childhood Leukaemia
4. First International Scientific Conference on Childhood Leukaemia
5. First ever standards linking climate change, biodiversity and poverty seek global peer review
6. First genetic comparison of purebred domestic dogs produces surprises
7. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
8. First target for childhood malaria vaccine
9. First study of resveratrol dietary supplement finds effect on breast and prostate cancers unlikely
10. First flavors form a lasting impression
11. STN International launches Derwent World Patents Index First View

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, a registered 501(c)(3) ... and aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: ... supporting the organization’s initiatives and overall vision. , "Senior Fellows are more than ...
(Date:6/28/2020)... ... ... In an upcoming episode scheduled for the fall of 2020, Advancements with Ted ... local listings for more info. , Today, the majority of testing is performed at ... the country. Results are then available several days later. Now, in an effort to ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... and monoclonal antibody development services, today announced that the company has received ... to the pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... ... 2020 , ... Introducing Ardent Animal Health – MediVet Biologics rebrands company and ... Known as MediVet Biologics since its formation in 2016, the company is relaunching itself ... will build on its base of innovative therapies for osteoarthritis and cancer. ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, ... provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell ... into a strategic partnership whereby Catalent will provide support for the development, manufacturing, ...
(Date:7/18/2020)... ... 2020 , ... After research model surgery and catheter implantation, the long journey ... the beginning of a successful study, while protecting and accessing the catheter or device ... of Surgery from Envigo in a live webinar on Wednesday, ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... that Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive license ... to move into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 ...
Breaking Biology Technology:
Cached News: